A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 223,600 shares of ELAN stock, worth $3.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
223,600
Previous 266,600 16.13%
Holding current value
$3.13 Million
Previous $3.85 Million 14.69%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.85 - $15.47 $509,550 - $665,210
-43,000 Reduced 16.13%
223,600 $3.28 Million
Q2 2024

Aug 14, 2024

SELL
$12.93 - $18.45 $1.14 Million - $1.63 Million
-88,300 Reduced 24.88%
266,600 $3.85 Million
Q1 2024

May 15, 2024

SELL
$14.37 - $16.46 $1.56 Million - $1.79 Million
-108,700 Reduced 23.45%
354,900 $5.78 Million
Q4 2023

Feb 14, 2024

SELL
$8.6 - $14.94 $131,580 - $228,582
-15,300 Reduced 3.19%
463,600 $6.91 Million
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $1.39 Million - $1.79 Million
-141,882 Reduced 22.86%
478,900 $5.38 Million
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $2.79 Million - $3.58 Million
-345,600 Reduced 35.76%
620,782 $6.25 Million
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $4.49 Million - $7.45 Million
510,900 Added 112.17%
966,382 $9.08 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $586,196 - $696,395
-51,018 Reduced 10.07%
455,482 $5.57 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $471,319 - $1.23 Million
37,979 Added 8.11%
506,500 $6.29 Million
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $6.64 Million - $9.01 Million
-338,482 Reduced 41.94%
468,521 $9.2 Million
Q1 2022

May 16, 2022

BUY
$24.65 - $29.0 $16.2 Million - $19 Million
655,632 Added 433.13%
807,003 $21.1 Million
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $2.49 Million - $3.06 Million
89,871 Added 146.13%
151,371 $4.3 Million
Q3 2021

Nov 15, 2021

BUY
$29.2 - $36.72 $1.8 Million - $2.26 Million
61,500 New
61,500 $1.96 Million
Q1 2020

May 15, 2020

SELL
$16.68 - $32.25 $556,911 - $1.08 Million
-33,388 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$25.29 - $29.45 $844,382 - $983,276
33,388 New
33,388 $983,000
Q3 2019

Nov 14, 2019

SELL
$25.62 - $34.96 $560,744 - $765,169
-21,887 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$31.11 - $34.79 $8 Million - $8.95 Million
-257,200 Reduced 92.16%
21,887 $740,000
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $7.13 Million - $8.07 Million
245,787 Added 738.1%
279,087 $8.95 Million
Q4 2018

Feb 14, 2019

BUY
$29.63 - $34.5 $986,679 - $1.15 Million
33,300 New
33,300 $1.05 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.